• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-羟色胺(5-HT3)受体拮抗剂。1. 吲唑和中氮茚-3-羧酸衍生物。

5-Hydroxytryptamine (5-HT3) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives.

作者信息

Bermudez J, Fake C S, Joiner G F, Joiner K A, King F D, Miner W D, Sanger G J

机构信息

Beecham Pharmaceuticals Research Division, Harlow, Essex, England.

出版信息

J Med Chem. 1990 Jul;33(7):1924-9. doi: 10.1021/jm00169a016.

DOI:10.1021/jm00169a016
PMID:2362270
Abstract

Metoclopramide (1) is a gastric motility stimulant and a weak dopamine and 5-HT3 receptor antagonist. Conformational restriction of the (diethylamino)ethyl side chain of 1 in the form of the azabicyclic tropane gave 3, a very potent gastric motility stimulant and 5-HT3 receptor antagonist but devoid of significant dopamine receptor antagonist properties. Subsequent alteration of the aromatic nucleus led to the identification of indazoles 6a-h, and 1- and 3-indolizines 7b-d and 8, and imidazo[1,5-alpha]pyridines 9 and 10, as potent 5-HT3 receptor antagonists devoid of either dopamine antagonist or gastric motility stimulatory properties. Further conformational restriction of the side chain identified quinuclidine 11 and isoquinuclidine 12 as potent 5-HT3 receptor antagonists which mimic the distorted chair conformation of the tropane with, in the case of 11, the N-methyl group axial. From these series, 6g (BRL 43694) was found to be both potent and selective and has been shown to be a very effective antiemetic agent against cytotoxic drug induced emesis both in the ferret and in man.

摘要

甲氧氯普胺(1)是一种胃动力刺激剂,也是一种弱多巴胺和5 - HT3受体拮抗剂。以氮杂双环托烷形式对1的(二乙氨基)乙基侧链进行构象限制得到3,它是一种非常有效的胃动力刺激剂和5 - HT3受体拮抗剂,但没有明显的多巴胺受体拮抗剂特性。随后对芳环的改变导致鉴定出吲唑6a - h、1 - 和3 - 中氮茚7b - d和8以及咪唑并[1,5 - α]吡啶9和10,它们是有效的5 - HT3受体拮抗剂,既没有多巴胺拮抗剂特性也没有胃动力刺激特性。对侧链进一步的构象限制确定了奎宁环11和异奎宁环12为有效的5 - HT3受体拮抗剂,它们模拟了托烷的扭曲椅式构象,对于11而言,N - 甲基基团为轴向。从这些系列中,发现6g(BRL 43694)既有效又有选择性,并且已被证明是一种非常有效的抗呕吐剂,可对抗雪貂和人类中细胞毒性药物引起的呕吐。

相似文献

1
5-Hydroxytryptamine (5-HT3) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives.5-羟色胺(5-HT3)受体拮抗剂。1. 吲唑和中氮茚-3-羧酸衍生物。
J Med Chem. 1990 Jul;33(7):1924-9. doi: 10.1021/jm00169a016.
2
Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.强效口服活性 5-羟色胺4(5-HT4)受体拮抗剂的合成及其构效关系:吲唑和苯并咪唑酮衍生物
J Med Chem. 1998 May 21;41(11):1943-55. doi: 10.1021/jm970857f.
3
Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.高亲和力5-羟色胺3受体拮抗剂的研发。2. 两种新型三环苯甲酰胺。
J Med Chem. 1992 Mar 6;35(5):903-11. doi: 10.1021/jm00083a015.
4
Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.新型强效5-羟色胺5-HT3和多巴胺D2受体双重拮抗剂——4-氨基-5-氯-N-(1,4-二烷基六氢-1,4-二氮杂卓-6-基)-2-甲氧基苯甲酰胺衍生物的合成及其构效关系
Chem Pharm Bull (Tokyo). 2002 Jul;50(7):941-59. doi: 10.1248/cpb.50.941.
5
The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.新型多巴胺D2、D3和5-羟色胺3(5-HT3)受体拮抗剂AS-8112的广谱止吐活性
Br J Pharmacol. 2001 May;133(2):253-60. doi: 10.1038/sj.bjp.0704078.
6
Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.新型N-(1-乙基-4-甲基六氢-1,4-二氮杂卓-6-基)吡啶-3-甲酰胺的合成及其与强效5-羟色胺5-HT3和多巴胺D2受体拮抗活性的构效关系
J Med Chem. 2003 Feb 27;46(5):702-15. doi: 10.1021/jm020270n.
7
5-Hydroxytryptamine (5-HT3) receptor antagonists. 2. 1-Indolinecarboxamides.5-羟色胺(5-HT3)受体拮抗剂。2. 1-吲哚啉甲酰胺类
J Med Chem. 1990 Jul;33(7):1929-32. doi: 10.1021/jm00169a017.
8
5-HT3 receptor antagonist effects of DAT-582, (R) enantiomer of AS-5370.DAT-582(AS-5370的R对映体)的5-羟色胺3型受体拮抗剂作用
Eur J Pharmacol. 1992 Jun 17;216(3):435-40. doi: 10.1016/0014-2999(92)90442-7.
9
Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists.喹喔啉衍生物作为新型5-羟色胺3受体拮抗剂的药理特性
Arzneimittelforschung. 1996 Apr;46(4):401-6.
10
5-Hydroxytryptamine (5-HT3) receptor antagonists. 3. Ortho-substituted phenylureas.5-羟色胺(5-HT3)受体拮抗剂。3. 邻位取代的苯基脲类化合物。
J Med Chem. 1990 Jul;33(7):1932-5. doi: 10.1021/jm00169a018.

引用本文的文献

1
The gut commensal attenuates indole-AhR signaling and restores ASD-like behaviors with BTBR mice.肠道共生菌减弱吲哚-AhR信号传导并恢复BTBR小鼠的类自闭症行为。
Front Microbiol. 2025 Aug 22;16:1640149. doi: 10.3389/fmicb.2025.1640149. eCollection 2025.
2
Regioselective alkylation of a versatile indazole: Electrophile scope and mechanistic insights from density functional theory calculations.一种通用吲唑的区域选择性烷基化:亲电试剂范围及密度泛函理论计算的机理见解
Beilstein J Org Chem. 2024 Aug 9;20:1940-1954. doi: 10.3762/bjoc.20.170. eCollection 2024.
3
Rapid synthesis of azoindolizine derivatives via aryldiazonium salts.
通过芳基重氮盐快速合成氮杂吲哚嗪衍生物。
Turk J Chem. 2024 Mar 11;48(3):506-511. doi: 10.55730/1300-0527.3675. eCollection 2024.
4
Borate esters: Simple catalysts for the sustainable synthesis of complex amides.硼酸酯:用于复杂酰胺可持续合成的简单催化剂。
Sci Adv. 2017 Sep 22;3(9):e1701028. doi: 10.1126/sciadv.1701028. eCollection 2017 Sep.
5
Chemical constituents in n-butanol fractions of Castus afer ker Gawl leaf and stem.刺果番荔枝叶和茎正丁醇部位的化学成分
J Intercult Ethnopharmacol. 2014 Apr-Jun;3(2):78-84. doi: 10.5455/jice.20140112010648. Epub 2014 May 20.
6
Identification and in vitro pharmacological characterization of a novel and selective α7 nicotinic acetylcholine receptor agonist, Br-IQ17B.新型选择性α7烟碱型乙酰胆碱受体激动剂Br-IQ17B的鉴定及体外药理学特性研究
Acta Pharmacol Sin. 2015 Jul;36(7):800-12. doi: 10.1038/aps.2015.9. Epub 2015 Apr 27.
7
Palladium-catalyzed carbonylative cyclization/arylation cascade for 2-aroylindolizine synthesis.钯催化的羰基环化/芳基化级联反应合成 2-酰基吲哚嗪。
Org Lett. 2012 Dec 7;14(23):6056-9. doi: 10.1021/ol302947r. Epub 2012 Nov 28.
8
High-affinity fluorescent ligands for the 5-HT(3) receptor.高亲和力荧光配体用于 5-HT(3)受体。
Bioorg Med Chem Lett. 2012 Jan 15;22(2):1151-5. doi: 10.1016/j.bmcl.2011.11.097. Epub 2011 Dec 1.
9
(6S,7S,8R,8aS)-6-Ethyl-perhydro-indolizine-7,8-diol.(6S,7S,8R,8aS)-6-乙基-全氢中氮茚-7,8-二醇
Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 16;66(Pt 7):o1666. doi: 10.1107/S1600536810021240.
10
Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.针对 5-HT3 受体的生物物理探针:格拉司琼衍生物的构效关系研究。
J Med Chem. 2010 Mar 11;53(5):2324-8. doi: 10.1021/jm901827x.